Online Program

295560
Review of the adverse childhood experience study (ACE)


Tuesday, November 5, 2013 : 9:20 a.m. - 9:40 a.m.

Melissa Merrick, PhD, National Center for Injury Prevention & Control, Division of Violence Prevention, Center for Disease Control and Prevention, Atlanta, GA
Child Maltreatment and other adverse childhood experiences impact physical and mental health and brain development across the lifespan. This presentation will review the Adverse Childhood Experiences (ACE) study, the health consequences of ACEs, and implications for prevention strategies, practice, and policies. Essentials for Childhood, CDC's strategic direction for child maltreatment prevention, which promotes safe, stable, nurturing relationships and environments for all children, will be reviewed. Also, examples of how several states are applying their ACE data to policy and practice will be highlighted.

Learning Areas:

Administer health education strategies, interventions and programs
Advocacy for health and health education
Epidemiology
Implementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs
Public health or related public policy

Learning Objectives:
Describe how child Maltreatment and other adverse childhood experiences impact physical and mental health and brain development across the lifespan Describe the Adverse Childhood Experiences (ACE) study Identify the health consequences of ACEs Define prevention strategies, practice, and policies Explain the CDC’s strategic direction for child maltreatment prevention

Keyword(s): Child Abuse, Child Health Promotion

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a Behaviorist Researcher at the Centers for Disease Control and Prevention and my area of research is Adverse Childhood Experiences and how they affect future growth and mental health issues. I have written several articles on this topic.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.